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Abstract
The identification of reproducible biological patterns from high-dimensional
data is a bottleneck for understanding the biology of complex illnesses such as
schizophrenia. To address this, we developed a biologically informed, multi-
stage machine learning (BioMM) framework. BioMM incorporates biological
pathway information to stratify and aggregate high-dimensional biological data.
We demonstrate the utility of this method using genome-wide DNA methylation
data and show that it substantially outperforms conventional machine learning ap-
proaches. Therefore, the BioMM framework may be a fruitful machine learning
strategy in high-dimensional data and be the basis for future, integrative analysis
approaches.
1 Introduction
The identification of predictive biological signatures from high-dimensional biological data remains
a major challenge. This particularly applies for clinically and biologically heterogeneous illnesses,
such as schizophrenia [11]. Schizophrenia is defined based on clinical symptom constellations, is
highly polygenic and is thought to result from complex gene-environment interactions. As a con-
sequence, effect sizes of individual biological markers is generally low, creating an opportunity for
machine learning approaches to identify more predictive biological fingerprints. Polygenic scores
integrating common variation across the genome explain a substantial amount of heritable variance,
but are not sufficiently predictive for diagnostic applications [15, 13]. Due to the importance of envi-
ronmental risk [2, 19, 1, 21], analysis of epigenetic modifications, such as DNAmethylation [6], has
received considerable attention in psychiatric research [14, 18]. The analysis of such epigenetic data
entails several challenges, including its sensitivity to confounding factors such as medication, which
have thus far limited the utility of this modality for integrative analytics in psychiatry. Due to the
high data dimensionality and frequently non-reproducible association signals, it remains to explored
whether schizophrenia is characterized by consistent patterns of abnormal DNA methylation. Here,
we aimed to develop a novel strategy to derive reproducible biological patterns from DNA methy-
lation data. Our approach builds on the hypothesis that biological stratification can meaningfully
reduce the dimensionality of the data. Specifically, inspired by functional genomics studies [16, 9],
we built a biologically informed two-stage learning framework. At the first level, machine learning
is performed independently on biological predictors (i.e. DNA methylation probes) harboured by
gene sets of different ontological categories. This is based on the hypothesis that these gene sets
capture at least partially independent, illness associated methylation effects. The predicted scores
were then used as input for machine learning at the second level, to identify a predictive methylation
pattern across ontological categories. Testing of the algorithm was performed in an independent test
dataset, to capture its robustness against cross-dataset heterogeneity. To evaluate the utility of this
strategy, we performed a comparative analysis against 5 conventional machine learning approaches.
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Table 1: Overview of demographic information
Meta-information Controls Cases Sex (m/f) Age
GEO:GSE80417 (phase 1 cohort) 322 353 396/279 40.5±15.2
GEO:GSE84727 (phase 2 cohort) 433 414 602/245 44.6±12.9
We demonstrate that the biologically informed, multi-stage machine learning significantly outper-
forms these conventional approaches.
2 Materials and Methods
2.1 Genome-wide methylation data
Genome-wide profiles of DNA methylation were obtained from two independent cohorts with a to-
tal sample number of 1522 (Table 1). Data were downloaded from the GEO database [4]. Detailed
descriptions of cohorts and data acquisition can be found elsewhere [7]. We focussed on the overlap-
ping set of autosomal methylation sites to limit the potential influence of sex on machine learning
due to the phenomenon of X chromosome inactivation or the existence of an additional X chromo-
some in female samples. The dataset GSE80417 was used as training set and GSE84727 for testing
(independent test set) of machine learning algorithms.
2.2 Adjustment for potential confounders
The data was corrected to account for the influence of potential confounders, which comprised
cigarette smoking [3], population structure [10], cellular composition, gender and age. Smoking
was quantified from DNA methylation levels as described previously [5, 22]. Population structure
was determined from methylation data via Principal Components Analysis. Specifically, the first 10
principal components were considered as covariates. Cellular composition was quantified using the
Epigenetic Clock tool (https://dnamage.genetics.ucla.edu/) [8] and included the seven rec-
ommended cell types: CD8.naive, CD8pCD28nCD45RAn, PlasmaBlast, CD4T, NK, Mono, Gran.
All covariates were used in a linear model to residualize each given methylation probe. This was
performed separately for both cohorts and the resulting residuals were used for downstream analysis.
2.3 Gene and ontological assignment
For each gene, we extracted all CpGs within 20Kb upstream and downstream of the transcription
start and end sites, respectively. CpG locations were downloaded from the NCBI database for both
datasets and gene boundaries from the R library TxDb.Hsapiens.UCSC.hg19.knownGene. Infor-
mation on gene ontologies was derived from the R library org.Hs.eg.db. In total, 2135 ontological
categories (biological processes only), each containing between 10 and 200 genes were used for
analysis.
2.4 BioMM algorithm
Input:
1. K: the total number of gene ontological categories (GO).
2. Dk: the stage-1 training set Dk = {((x
k
1
, ...xk
M
), YD)} with M samples for every k = 1, ...,
K and a fixed label YD.
3. Rk: the stage-1 independent test set Rk = {((x
k
1
, ...xk
N
), YR)} with N samples for every k
= 1, ..., K and a fixed label YR.
4. f1: the stage-1 model.
5. f2: the stage-2 model. The random forest algorithm was used in the present study.
Output:
1. Yˆ 1
kM
: the stage-1 bootstrapping prediction score with M samples for kth GO.
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Table 2: Classification performance (quantified as error rates) of conventional classifiers and BioMM
Classifiers Random forest SVM logit LASSO Elastic
Conventional_Errtest 0.511 0.519 0.514 0.515 0.514
BioMM_Errtest 0.391 0.432 0.482 0.509 0.502
2. Yˆ 1
kN
: the stage-1 independent test prediction score with N samples for kth GO.
3. D2: the stage-2 training set D2 = (Yˆ 1
1M
, . . . , Yˆ 1
KM
, YD) with M samples and the label YD .
4. R2: the stage-2 test set R2 = (Yˆ 1
1N
, . . . , Yˆ 1
KN
, YR) with N samples and the label YR.
5. Yˆ 2test: the stage-2 test estimate.
6. Errtest: the error rate for the stage-2 test estimate. Errtest = L(YR, Yˆ
2
test
) with the 0-1
loss function L.
BioMM 1st stage:
1. For each ontological category k, repeat the following steps B times (here, B=100):
(a) Draw a bootstrap set fromDk with the same sample size. The out-of-bag samples are
used as test set.
(b) Fit a machine learning model f1 to the bootstrapped data.
(c) Predict the model on the test set and Rk.
2. For each GO k, determine the averaged prediction score Yˆ 1
kMavg
= 1
B
∑B
b=1
Yˆ 1
kM
and
Yˆ 1
kNavg
= 1
B
∑
B
b=1
Yˆ 1
kN
.
3. Combine Yˆ 1
kMavg
and Yˆ 1
kNavg
across allK GOs to generateD2 and R2.
BioMM 2nd stage:
1. Fit a machine learning model f2 toD2 with features that are positively correlated with YD .
2. Predict the model on R2 with the corresponding feature set.
3. Repeat steps 1 and 2 20 times and average prediction scores to obtain Yˆ 2
test
.
4. Determine Errtest to evaluate the model performance.
2.5 Classifier selection
To compare classifiers regarding performance, five different well-known classifiers were used as ma-
chine learning models for the first stage of BioMM: random forests, support vector machine (SVM)
with the radial basis function kernel, logit regression, the LASSO and elastic net. No variable se-
lection was performed since the categorization based on ontological categories already substantially
reduced data dimensionality. At the second stage, the random forest algorithm was applied to cap-
ture potential interactions between ontological categories.
2.6 Comparison against conventional machine learning
The same five classifiers were used as conventional machine learning tools to compare performance
against the BioMM method. Due to the large data dimensionality, variable selection was performed
based on Pearson correlation filtering. The number of selected features (5, 10, 20, 30, 50, 100, 500,
1000 or 3000 CpGs) was determined using bootstrapping in the training data.
3 Results and Discussion
Table 2 shows that BioMM using random forests outperformed conventional and other BioMM ap-
proaches, with a classification error rate of 39.1%. The second best classifier was BioMM using
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SVM. The superior performance of BioMM using random forests may have been due to the fol-
lowing reasons: (I) Random forests can better capture interactions between predictors, compared to
the remaining models. Notably, application of conventional random forests was not able to yield
comparative performance, likely due to the fact that variable selection was also based on a linear
method. Similarly, non-linear SVM using radial basis functions, showed substantially better perfor-
mance as part of the BioMM, compared to conventional machine learning approach. The possible
advantage of capturing predictor interactions would relate to interactions of individual methylation
sites only, since there was no pathway-level aggregation for conventional machine learning and all
second stage aggregation part of BioMM applications were performed using random forests. (II)
An interesting aspect of the BioMM method is that, in contrast to conventional machine learning,
there is redundancy in the predictor set that may impact positively on classification. The redundancy
arising from gene overlap between ontological categories creates the possibility for the same methy-
lation probes to be part of different rules, potentially exploiting better additive and multiplicative
effects [20]. The ontological stratification of methylation sites may yield second-stage predictors
that are independently associated with outcome and therefore lead to an increase in classification
performance. These independent effects may be lost in non-stratified data due to its high dimension-
ality. (III) Repeated sampling at the first and second stage can average over sampling variability and
lead to predictions with higher biological reproducibility (1st stage) and accuracy (2nd stage). (IV)
Illness associated methylation differences may be hierarchically organized such that alterations of
individual methylation sites impact first at the pathway level which subsequently leads to a systems-
wide effect.
The BioMMmethod conceptually aligns well with the growing consensus that schizophrenia is not a
single disease entity, but composed of multiple subtypes with different biological underpinnings. In
contrast to conventional machine learning (as well as the variable selection performed here), which
generally builds on the assumption that all subjects originate from the same population, BioMM
adds a dimension of biological stratification. It specifically exploits the hypothesis that some sub-
jects may have alterations in a given biological process (thereby receiving high prediction scores at
the first stage) and these subgroups of patients are then integrated at the second stage. Therefore,
exploring how first stage predictors distribute across the patient cohorts may give novel insights into
the presence of potential patient subgroups. This may allow a personalized extension functional anal-
ysis, which had previously been performed on synthetic features similar to those created by BioMM
after first stage computations [16, 9]. Notably, these features do not allocate subjects to mutually
exclusive clusters but may elucidate overlapping patient communities depending on the implicated
biological processes. In the present study, we have corrected data for several potential confound-
ing effects that are known to modify DNA methylation levels. However, we cannot exclude that
other factors, such as medication or lifestyle effects, may have introduced bias and led to artifactual
illness-associated profiles. Therefore, the present results should be replicated in additional cohorts
that are not affected by these confounders. Results from conventional machine learning, as well as
the BioMM method using some first-stage classifiers, however, demonstrate that these effects did
not lead to obvious signatures that were reproducible across datasets. The resulting signatures may,
therefore, hint at the existence of reproducible methylation signatures in schizophrenia and show
utility for integrative analyses with other data modalities.
From a computational perspective, further improvements to the method may be achieved by variable
selection during the first and second stage. At the second stage, we selected predictors positively
associated with outcome in the training data to prevent confounding, but more advanced variable
selection procedures may further improve performance [17]. Additionally, especially if larger data
sets are available, other strategies of creating ‘synthetic’ data sets during the first stage may be prefer-
able. Here, we used the oob predictions, but these have been reported to be conservatively biased
[12]. This could impact on the comparability between the synthetic training and test data, which
could, in turn, negatively impact on classifier performance. Another potential concern is that given
the high number of ontological categories used for stratification, some synthetic features will likely
show illness associations by chance and, therefore, receive high classifier weights at the second
level. This is particularly a problem if the true biological signal is weak and distributed across nu-
merous ontological categories. Besides additional data to remove false-positive associations, other
data modalities or biological meta-information, such as tissue specific expression information, may
help to focus on biologically relevant signals. Finally, we expect the BioMM strategy to be a fruitful
approach for integration of multiple data modalities that can be mapped via genetic and ontological
information, such as with genetic association or expression data.
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4 Conclusion
We have developed here a biologically informedmachine learning framework that aims to identify re-
producible biological patterns through biological stratification and aggregation of high-dimensional
data. This BioMM method outperformed conventional machine learning approaches based on eval-
uation of prediction in independent test data. This computational framework may allow the explo-
ration of patient subgroup effects and show utility for integrative analyses with other data modalities.
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